Doyle John Brendan 4
4 · COGNITION THERAPEUTICS INC · Filed May 3, 2023
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-01+109,824→ 109,824 total - Award
Stock Option (right to buy)
2023-05-01+109,824→ 109,824 totalExercise: $1.65Exp: 2033-05-01→ Common Stock (109,824 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.